On the contrary, results from the Canakinumab Anti-Inflammatory Thrombosis Outcome Study (CANTOs) showed that IL-1β might not be linked to hypertension given that hypertension did not improve in patients given the IL-1β inhibitor Canakinumab [22]. The gene discussed is IL1B; the disease is hypertensive disorder.